Global Adhesion Barrier Market to Reach USD 1,267.89 Million by 2031 | CAGR of 7.3%
Category : Pharmaceuticals And Healthcare | Published Date : Nov 2024 | Type : Press Release
Adhesion Barrier Market Scope & Overview:
As per the Consegic Business Intelligence newly published report, the Adhesion Barrier Market was valued at USD 720.11 Million in 2023 and is projected to reach USD 1,267.89 Million by 2031, growing at a CAGR of 7.3% from 2024 to 2031. Adhesion barriers are specialized medical devices designed to prevent the formation of fibrous bands, known as adhesions, between tissues and organs after surgery. These barriers, made from biocompatible, biodegradable materials such as films, gels, and liquids, act as a temporary physical separation to reduce tissue attachment during the healing process.
The report comprises the Adhesion Barrier Market Share, Size & Industry Analysis, By Product Type (Film Adhesion Barriers, Gel Adhesion Barriers, Liquid Adhesion Barriers), By Application (Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutes & Academic Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024–2031.
The report contains detailed information on Adhesion Barrier Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Increasing utilization of adhesion barriers in gynecological and minimally invasive surgeries drives market growth, while high costs and limited insurance coverage restrain broader adoption.
Segmental Analysis :
By Product Type, the market is segmented into Film Adhesion Barriers, Gel Adhesion Barriers, and Liquid Adhesion Barriers.
- Film Adhesion Barriers accounted for the largest revenue share of 53.52% in 2023 due to their proven efficacy and ease of application in surgeries like abdominal and pelvic procedures.
- Gel Adhesion Barriers are anticipated to register the fastest CAGR during the forecast period, driven by their adaptability in minimally invasive surgeries and complex anatomical structures.
By Application, the market includes Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, and Others.
- Gynecological Surgeries held the largest market share in 2023, propelled by the high incidence of postoperative adhesions and complications in procedures like hysterectomies and C-sections.
- Orthopedic Surgeries are expected to register the fastest CAGR, supported by the increasing adoption of adhesion barriers in joint replacements and trauma-related operations.
By End-User, the market is categorized into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, and Research Institutes & Academic Centers.
- Hospitals dominated the market share in 2023 due to the high volume of complex surgical procedures performed and access to advanced medical products.
- Ambulatory Surgical Centers (ASCs) are projected to grow at the highest rate, driven by a trend towards outpatient surgeries and cost-effective surgical solutions.
Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America led the market in 2023 with a significant share, attributed to the advanced healthcare infrastructure and high volume of surgical procedures.
- Asia-Pacific is expected to exhibit the highest growth rate, supported by increasing healthcare expenditure, rising medical tourism, and the growing adoption of minimally invasive procedures in countries like China, India, and Japan.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 1,267.89 Million |
| CAGR (2024-2031) | 7.3% |
| By Product Type | Film Adhesion Barriers, Gel Adhesion Barriers, Liquid Adhesion Barriers |
| By Application | Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Others |
| By End-User | Hospitals, ASCs, Specialty Clinics, Research Institutes & Academic Centers |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Adhesion Barrier Industry:
- Baxter International Inc.-(US)
- Johnson & Johnson Private Limited – (US)
- Becton, Dickinson, and Company (BD) – (US)
- Integra LifeSciences Corporation – (US)
- Anika Therapeutics, Inc. – (US)
- FzioMed, Inc. – (US)
- MAST Biosurgery USA, Inc. – (US)
- Getinge AB – (Europe)
- Innocoll Holdings PLC – (Europe)
- Terumo Corporation – (Europe)
Recent Industry Developments :
- In February 2022, Gunze Limited received medical device approval for TENALEAF, an absorbable adhesion barrier blade, expanding its product portfolio and application range in surgical settings.
- In January 2021, Integra LifeSciences Corporation introduced a new bioresorbable film adhesion barrier designed to prevent adhesions in soft tissue surgeries, enhancing its offerings in advanced surgical care.
